Age-related decline in striatal dopamine release and motoric function in Brown Norway/Fischer 344 hybrid rats

Brain Research

Volumn 791, Issue 1-2, 1998, Pages 246-256

  Yurek, David M ^a   Hipkens, Susan B ^a   Hebert, Meleik A ^b   Gash, Don M ^a   Gerhardt, Greg A ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Neurosci Train Prog Rocky Mt C   (United States)

Author keywords

3,4 Dihydroxyphenylacetic acid; 4 Hydroxy 3 methoxyphenylacetic acid; Aging; D amphetamine; F344BNF1 rat; Microdialysis

Indexed keywords

AGING; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; LOCOMOTION; MALE; MICRODIALYSIS; MOTOR PERFORMANCE; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; RAT;

AGING; ANIMALS; BASAL METABOLISM; BIOGENIC MONOAMINES; CORPUS STRIATUM; DOPAMINE; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NEUROTRANSMITTER AGENTS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, INBRED BN; RATS, INBRED F344;

EID: 0032571793     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00110-3     Document Type: Article

References (45)

1. 3H] GBR 12935 in human putamen. Neurobiol. Aging. 10:1989;661-664.
2. Bannon M.J., Poosch M.S., Xia Y., Goebel D.J., Cassin B., Kapatos G. Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7095-7099.
3. Bennett D.A., Beckett L.A., Murray A.M., Shannon K.M., Goetz C.G., Pilgrim D.M., Evans D.A. Prevalence of parkinsonian signs and associated mortality in a community population of older people. New Engl. J. Med. 334:1996;71-76.
4. Burwell R.D., Gallagher M. A longitudinal study of reaction time performance in Long-Evans rats. Neurobiol. Aging. 14:1993;57-64.
5. Burwell R.D., Lawler C.P., Gallagher M. Mesostriatal dopamine markers in aged Long-Evans rats with sensorimotor impairment. Neurobiol. Aging. 16:1995;175-186.
6. Carlsson A., Winblad B. Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. J. Neural Transm. 38:1976;271-276.
7. Crawford C.A., Levine M.S. Dopaminergic function in the neostriatum and nucleus accumbens of young and aged Fischer 344 rats. Neurobiol. Aging. 18:1996;57-66.
8. Demarest K.T., Riegle G.D., Moore K.E. Characteristics of dopaminergic neurons in the aged male rat. Neuroendocrinology. 31:1980;222-227.
9. Fearnley J.M., Lees A.J. Aging and Parkinson's disease: substantia nigra regional selectivity. Brain. 114:1992;2283-2301.
10. Felten D.L., Felten S.Y., Fuller R.W., Romano T.D., Smalstig E.B., Wong D.T., Clemens J.A. Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged-Fischer-344 rats. Neurobiol. Aging. 13:1992;339-351.
11. Finch C.E. Catecholamine metabolism in the brains of ageing male mice. Brain Res. 52:1973;261-276.
12. Fink-Jensen A., Ingwersen S.H., Nielsen P.G., Hansen L., Nielsen E.B., Jon Hansen A. Halothane anesthesia enhances the effect of dopamine uptake inhibition on interstitial levels of striatal dopamine. Naunyn-Schmiedeberg's Arch. Pharmacol. 350:1994;239-244.
13. Friedemann M.N., Gerhardt G.A. Regional effects of Aging on dopaminergic function in the Fischer-344 rat. Neurobiol. Aging. 13:1992;325-332.
14. A. Goodman, A. Gilman, in: A. Gilman, L.S. Goodman, T.W. Rall, F. Murad (Eds.), The Pharmacological Basis of Therapeutics, Macmillan, New York, NY, 1985.
15. Gozlan H., Daval G., Verge D., Spampinato U., Fattaccini C.M., Gallissot M.C., el Mestikawy S., Hamon M. Aging associated changes in serotoninergic and dopaminergic pre- and post-synaptic neurochemical markers in the rat brain. Neurobiol. Aging. 11:1990;437-449.
16. Hall M.E., Hoffer B.J., Gerhardt G.A. Rapid and sensitive determination of catecholamines in small tissue samples by high pressure liquid chromatography coupled with dual-electrode coulometric electrochemical detection. LC/GC. 7:1989;258-265.
17. Jonec V.J., Finch C.E. Senescence and dopamine uptake by subcellular fractions of the C57BL/6 male mouse brain. Brain Res. 91:1975;197-215.
18. Joseph J.A., Berger R.E., Engel B.T., Roth G.S. Age-related changes in the nigrostriatum: a behavioral and biochemical analysis. J. Gerontol. 33:1978;643-649.
19. Joseph J.A., Dalton T.K., Hunt W.A. Age-related decrements in muscarinic enhancement of K+-evoked release of endogenous striatal dopamine: an indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence. Brain Res. 454:1988;140-148.
20. Kametani H., Iijima S., Spangler E.L., Ingram D.K., Joseph J.A. In vivo assessment of striatal dopamine release in the aged male Fischer 344 rat. Neurobiol. Aging. 16:1995;639-646.
21. Kish S.J., Shannak K., Rajput A., Deck J.H.M., Hornykiewicz O. Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease. J. Neurol. Sci. 53:1992;347-357.
22. Lipman R.D., Chrisp C.E., Hazzard D.G., Bronson R.T. Pathologic characterization of Brown Norway, Brown Norway X Fischer 344, and Fischer 344 X Brown Norway rats with relation to age. J. Gerontol. 51A:1996;B54-B59.
23. Marshall J.F., Altar C.A. Striatal dopamine uptake and swim performance of the aged rat. Brain Res. 379:1986;112-117.
24. Marshall J.F., Berrios N. Movement disorders in aged rats: reversal by dopamine receptor stimulation. Science. 206:1979;477-479.
25. Marshall J.F., Rosenstein A.J. Age-related decline in rat striatal dopamine metabolism is regionally homogeneous. Neurobiol. Aging. 11:1990;131-137.
26. McGeer P.L., McGeer E.G. Aging and extrapyramidal function. Arch. Neurol. 34:1977;33-35.
27. McGeer E.G., Fibiger H.C., McGeer P.L., Wickson V. Aging and brain enyzmes. Exp. Gerontol. 6:1971;391-396.
28. McIntosh H.H., Westfall T.C. Influence of aging on catecholamine levels, accumulation, and release in F344 rats. Neurobiol. Aging. 8:1987;233-239.
29. McNeill T.H., Koek L.L. Differential effects of advancing age on neurotransmitter cell loss in the substantia nigra and striatum of C57BL/6N mice. Brain Res. 521:1990;107-117.
30. Miyano K., Tanifuji Y., Eger E.I. The effect of halothane dose on striatal dopamine: an in vivo microdialysis study. Brain Res. 605:1993;342-344.
31. Osborne P.G., O'Connor W.T., Drew K.L., Ungerstedt U. An in vivo microdialysis characterization of extracellular dopamine and GABA in dorsolateral striatum of awake freely moving and halothane anaesthetised rats. J. Neurosci. Methods. 34:1990;99-105.
32. Osterburg H.H., Donahue H.G., Severson J.A., Finch C.E. Catecholamine levels and turnover during aging in brain regions of male C57BL/6J mice. Brain Res. 224:1981;337-352.
33. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1982.
34. Robinson T.E., Whishaw I.Q. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res. 450:1988;209-224.
35. Rose G.M., Gerhardt G.A., Conboy G.L., Hoffer B.J. Age-related alterations in monoamine release from rat striatum: an in vivo electrochemical study. Neurobiol. Aging. 7:1986;77-82.
36. Sabel B.A., Stein D.G. Extensive loss of subcortical neurons in the aging rat brain. Exp. Neurol. 73:1981;507-516.
37. Severson J.A., Finch C.E. Reduced dopaminergic binding during aging in the rodent striatum. Brain Res. 192:1980;147-162.
38. 3H]dopamine uptake in rat striatum during aging. J. Neurochem. 56:1991;575-579.
39. Spangler E.L., Waggie K.S., Hengemihle J., Roberts D., Hess B., Ingram D.K. Behavioral assessment of aging in male Fischer 344 and Brown Norway rat strains and their F1 hybrid. Neurobiol. Aging. 15:1994;319-328.
40. Sprott R.L. Development of animal models of aging at the National Institute on Aging. Neurobiol. Aging. 12:1991;635-638.
41. Stamford J.A. Development and ageing of the rat nigrostriatal dopamine system studied with fact cyclic voltammetry. J. Neurochem. 52:1989;1582-1589.
42. Wallace J.E., Krauter E., Campbell B.A. Motor and reflexive behavior in the aging rat. J. Gerontol. 35:1980;364-370.
43. Watanabe H. Differential decrease in the rate of dopamine synthesis in several dopaminergic neurons of aged rat brain. Exp. Gerontol. 22:1987;17-25.
44. Zelnik N., Angel I., Paul S.M., Kleinman J.E. Decreased density of human striatal dopamine uptake sites with age. Eur. J. Pharmacol. 126:1986;175-176.
45. Zetterström T., Sharp T., Marsden C.A., Ungerstedt U. In vivo measurements of dopamine and its metabolites by intracerebral dialysis: changes after D-amphetamine. J. Neurochem. 41:1983;1769-1773.